Analysis of short-term reproducibility of arterial vasoreactivity by pulse-wave analysis after pharmacological challenge

Biju Paul, Christopher L Hewitson, Richard J Woodman, Arduino Aleksander Mangoni

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

1. Pulse-wave analysis (PWA) is an established method to assess arterial wave reflections and arterial vasoreactivity in humans. A high short-term reproducibility of baseline augmentation index (AIx) has been reported. However, the short-term reproducibility of AIx changes following pharmacological challenge with either inhaled salbutamol (endothelium-dependent vasodilatation) or sublingual glyceryl trinitrate (GTN; endothelium-independent vasodilatation), using appropriate statistical methods, is largely unknown. 2. Baseline AIx and GTN- and salbutamol-mediated changes in AIx (all corrected for a heart rate of 75 b.p.m.) were measured on two separate occasions, 1 h apart, in 22 healthy controls (mean (+/-SD) age 52.0 +/- 13.4 years) and 11 elderly patients with chronic heart failure (CHF; 73.1 +/- 8.7 years). Reproducibility was assessed by measuring intraclass correlation coefficients (ICC), coefficients of variation (CV) and Bland-Altman plots. 3. Baseline AIx showed good short-term reproducibility with high ICC in both the control and CHF groups (0.90 and 0.87, respectively). In contrast, in the control and CHF groups, the ICC of GTN- (0.58 and 0.17, respectively) and salbutamol-mediated (0.18 and 0.04, respectively) changes in AIx were substantially low. The CV was relatively low for baseline AIx in control and CHF groups (25.0 and 22.5%, respectively), but not for GTN- (22.3 and 59.8%, respectively) or salbutamol-mediated (45.1 and 184.0%, respectively) changes in AIx. Bland-Altman analysis revealed poor reproducibility, with limits of agreement beyond either +15% or -15% for changes in AIx after GTN and salbutamol for both control and CHF groups. The changes in blood pressure and heart rate following pharmacological challenge were similar between the two measurements. 4. The poor reproducibility of changes in AIx following pharmacological challenge questions the use of this method in acute studies.
Original languageEnglish
Pages (from-to)49-54
Number of pages6
JournalClinical and Experimental Pharmacology & Physiology
Volume36
Issue number1
Early online date28 Aug 2008
DOIs
Publication statusPublished - Jan 2009

Fingerprint

Pulse Wave Analysis
Albuterol
Pharmacology
Control Groups
Vasodilation
Endothelium
Heart Rate
Nitroglycerin
Heart Failure
Blood Pressure

Keywords

  • Adrenergic beta-Agonists
  • Adult
  • Aged
  • Aged, 80 and over
  • Albuterol
  • Endothelium, Vascular
  • Female
  • Heart Failure
  • Humans
  • Male
  • Middle Aged
  • Nitroglycerin
  • Radial Artery
  • Reproducibility of Results
  • Vasoconstriction
  • Vasodilation
  • Vasodilator Agents
  • augmentation index
  • endothelium
  • pulse-wave analysis
  • repeatability
  • reproducibility
  • vasodilatation

Cite this

Analysis of short-term reproducibility of arterial vasoreactivity by pulse-wave analysis after pharmacological challenge. / Paul, Biju; Hewitson, Christopher L; Woodman, Richard J; Mangoni, Arduino Aleksander.

In: Clinical and Experimental Pharmacology & Physiology, Vol. 36, No. 1, 01.2009, p. 49-54.

Research output: Contribution to journalArticle

Paul, Biju ; Hewitson, Christopher L ; Woodman, Richard J ; Mangoni, Arduino Aleksander. / Analysis of short-term reproducibility of arterial vasoreactivity by pulse-wave analysis after pharmacological challenge. In: Clinical and Experimental Pharmacology & Physiology. 2009 ; Vol. 36, No. 1. pp. 49-54.
@article{30e23a560ad04bce9017b74a2ef0ae3a,
title = "Analysis of short-term reproducibility of arterial vasoreactivity by pulse-wave analysis after pharmacological challenge",
abstract = "1. Pulse-wave analysis (PWA) is an established method to assess arterial wave reflections and arterial vasoreactivity in humans. A high short-term reproducibility of baseline augmentation index (AIx) has been reported. However, the short-term reproducibility of AIx changes following pharmacological challenge with either inhaled salbutamol (endothelium-dependent vasodilatation) or sublingual glyceryl trinitrate (GTN; endothelium-independent vasodilatation), using appropriate statistical methods, is largely unknown. 2. Baseline AIx and GTN- and salbutamol-mediated changes in AIx (all corrected for a heart rate of 75 b.p.m.) were measured on two separate occasions, 1 h apart, in 22 healthy controls (mean (+/-SD) age 52.0 +/- 13.4 years) and 11 elderly patients with chronic heart failure (CHF; 73.1 +/- 8.7 years). Reproducibility was assessed by measuring intraclass correlation coefficients (ICC), coefficients of variation (CV) and Bland-Altman plots. 3. Baseline AIx showed good short-term reproducibility with high ICC in both the control and CHF groups (0.90 and 0.87, respectively). In contrast, in the control and CHF groups, the ICC of GTN- (0.58 and 0.17, respectively) and salbutamol-mediated (0.18 and 0.04, respectively) changes in AIx were substantially low. The CV was relatively low for baseline AIx in control and CHF groups (25.0 and 22.5{\%}, respectively), but not for GTN- (22.3 and 59.8{\%}, respectively) or salbutamol-mediated (45.1 and 184.0{\%}, respectively) changes in AIx. Bland-Altman analysis revealed poor reproducibility, with limits of agreement beyond either +15{\%} or -15{\%} for changes in AIx after GTN and salbutamol for both control and CHF groups. The changes in blood pressure and heart rate following pharmacological challenge were similar between the two measurements. 4. The poor reproducibility of changes in AIx following pharmacological challenge questions the use of this method in acute studies.",
keywords = "Adrenergic beta-Agonists, Adult, Aged, Aged, 80 and over, Albuterol, Endothelium, Vascular, Female, Heart Failure, Humans, Male, Middle Aged, Nitroglycerin, Radial Artery, Reproducibility of Results, Vasoconstriction, Vasodilation, Vasodilator Agents, augmentation index, endothelium , pulse-wave analysis, repeatability, reproducibility, vasodilatation",
author = "Biju Paul and Hewitson, {Christopher L} and Woodman, {Richard J} and Mangoni, {Arduino Aleksander}",
year = "2009",
month = "1",
doi = "10.1111/j.1440-1681.2008.05033.x",
language = "English",
volume = "36",
pages = "49--54",
journal = "Clinical and Experimental Pharmacology & Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Analysis of short-term reproducibility of arterial vasoreactivity by pulse-wave analysis after pharmacological challenge

AU - Paul, Biju

AU - Hewitson, Christopher L

AU - Woodman, Richard J

AU - Mangoni, Arduino Aleksander

PY - 2009/1

Y1 - 2009/1

N2 - 1. Pulse-wave analysis (PWA) is an established method to assess arterial wave reflections and arterial vasoreactivity in humans. A high short-term reproducibility of baseline augmentation index (AIx) has been reported. However, the short-term reproducibility of AIx changes following pharmacological challenge with either inhaled salbutamol (endothelium-dependent vasodilatation) or sublingual glyceryl trinitrate (GTN; endothelium-independent vasodilatation), using appropriate statistical methods, is largely unknown. 2. Baseline AIx and GTN- and salbutamol-mediated changes in AIx (all corrected for a heart rate of 75 b.p.m.) were measured on two separate occasions, 1 h apart, in 22 healthy controls (mean (+/-SD) age 52.0 +/- 13.4 years) and 11 elderly patients with chronic heart failure (CHF; 73.1 +/- 8.7 years). Reproducibility was assessed by measuring intraclass correlation coefficients (ICC), coefficients of variation (CV) and Bland-Altman plots. 3. Baseline AIx showed good short-term reproducibility with high ICC in both the control and CHF groups (0.90 and 0.87, respectively). In contrast, in the control and CHF groups, the ICC of GTN- (0.58 and 0.17, respectively) and salbutamol-mediated (0.18 and 0.04, respectively) changes in AIx were substantially low. The CV was relatively low for baseline AIx in control and CHF groups (25.0 and 22.5%, respectively), but not for GTN- (22.3 and 59.8%, respectively) or salbutamol-mediated (45.1 and 184.0%, respectively) changes in AIx. Bland-Altman analysis revealed poor reproducibility, with limits of agreement beyond either +15% or -15% for changes in AIx after GTN and salbutamol for both control and CHF groups. The changes in blood pressure and heart rate following pharmacological challenge were similar between the two measurements. 4. The poor reproducibility of changes in AIx following pharmacological challenge questions the use of this method in acute studies.

AB - 1. Pulse-wave analysis (PWA) is an established method to assess arterial wave reflections and arterial vasoreactivity in humans. A high short-term reproducibility of baseline augmentation index (AIx) has been reported. However, the short-term reproducibility of AIx changes following pharmacological challenge with either inhaled salbutamol (endothelium-dependent vasodilatation) or sublingual glyceryl trinitrate (GTN; endothelium-independent vasodilatation), using appropriate statistical methods, is largely unknown. 2. Baseline AIx and GTN- and salbutamol-mediated changes in AIx (all corrected for a heart rate of 75 b.p.m.) were measured on two separate occasions, 1 h apart, in 22 healthy controls (mean (+/-SD) age 52.0 +/- 13.4 years) and 11 elderly patients with chronic heart failure (CHF; 73.1 +/- 8.7 years). Reproducibility was assessed by measuring intraclass correlation coefficients (ICC), coefficients of variation (CV) and Bland-Altman plots. 3. Baseline AIx showed good short-term reproducibility with high ICC in both the control and CHF groups (0.90 and 0.87, respectively). In contrast, in the control and CHF groups, the ICC of GTN- (0.58 and 0.17, respectively) and salbutamol-mediated (0.18 and 0.04, respectively) changes in AIx were substantially low. The CV was relatively low for baseline AIx in control and CHF groups (25.0 and 22.5%, respectively), but not for GTN- (22.3 and 59.8%, respectively) or salbutamol-mediated (45.1 and 184.0%, respectively) changes in AIx. Bland-Altman analysis revealed poor reproducibility, with limits of agreement beyond either +15% or -15% for changes in AIx after GTN and salbutamol for both control and CHF groups. The changes in blood pressure and heart rate following pharmacological challenge were similar between the two measurements. 4. The poor reproducibility of changes in AIx following pharmacological challenge questions the use of this method in acute studies.

KW - Adrenergic beta-Agonists

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Albuterol

KW - Endothelium, Vascular

KW - Female

KW - Heart Failure

KW - Humans

KW - Male

KW - Middle Aged

KW - Nitroglycerin

KW - Radial Artery

KW - Reproducibility of Results

KW - Vasoconstriction

KW - Vasodilation

KW - Vasodilator Agents

KW - augmentation index

KW - endothelium

KW - pulse-wave analysis

KW - repeatability

KW - reproducibility

KW - vasodilatation

U2 - 10.1111/j.1440-1681.2008.05033.x

DO - 10.1111/j.1440-1681.2008.05033.x

M3 - Article

C2 - 18759856

VL - 36

SP - 49

EP - 54

JO - Clinical and Experimental Pharmacology & Physiology

JF - Clinical and Experimental Pharmacology & Physiology

SN - 0305-1870

IS - 1

ER -